US contract development and manufacturing organization (CDMO) Piramal Pharma Solutions (PPS), part of India-headquartered Piramal Pharma, plans to invest $80 million for...
Piramal Pharma Solutions has announced plans to invest a total of £55 million in two expansions at Grangemouth, Scotland, and Morpeth, UK. The Indian CDMO said the...
27.01.2020
- Piramal Enterprises Ltd., part of Indian conglomerate Piramal Group, has agreed to sell its healthcare insights and analytics business Decision Resources Group (DRG) to Clarivate...
11.11.2019
- On the occasion of the pharma trade show CPhI Worldwide 2019, which took place in Frankfurt on November 5-7, CPhI has released its annual report, analyzing key trends and...
19.09.2018
- Having successfully executed over 70 integrated programs with customers, Piramal Pharma Solutions has ample experience in managing multinational project teams. This article...
19.09.2018
- With its pending $425-million acquisition of Halo Pharmaceuticals, Cambrex joins other contract providers that have used acquisitions in recent years to build end-to-to end service...
14.09.2017
- Piramal Pharma Solutions (PPS) has appointed John Fowler as its Chief Operating Officer (COO). PPS is a leader in Integrated Contract Development and Manufacturing, with a global...
Growth in the global oncology drug market is an important measure of opportunities in drug development and manufacturing, including for contract manufacturers of active...
